Galiximab (Anti-CD28L / CD80)

Ask supplier a question | View on supplier's website

Galiximab (Anti-CD28L/CD80) is a primatized immunoglobulin G1 (IgG1) lambda monoclonal antibody targeting against the CD80 antigen. Galiximab has variable regions are primatized (cynomologous monkeys), and the constant regions are human. Galiximab can be used in research of B-cell lymphoma. MW:145.5 KD.

Supplier	Selleck Chemicals
Product #	A2559
Sku #	A2559-1mg*25
Pricing	1mg*25, $5070.00

Feedback